Follow-up, study design and outcome parameters

EuroIntervention

Volumn 9, Issue , 2013, Pages R96-R100

  Volpe, Massimo ^a,b   Battistoni, Allegra ^a   Tocci, Giuliano ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

Author keywords

Adverse effect; Follow up; Outcome parameters; Renal denervation; Resistant hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLUCOSE;

ANTIHYPERTENSIVE THERAPY; ARTERY DISSECTION; ARTICLE; BLOOD ANALYSIS; BLOOD CELL COUNT; BLOOD PRESSURE MONITORING; BRADYCARDIA; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIASTOLIC BLOOD PRESSURE; DOPPLER FLOWMETRY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ESTIMATED GLOMERULAR FILTRATION RATE; FALSE ANEURYSM; FOLLOW UP; GLUCOSE METABOLISM; HEMATOMA; HUMAN; INJURY; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; LONG TERM CARE; LOW BACK PAIN; MAGNETIC RESONANCE ANGIOGRAPHY; MECHANICAL INJURY; METHODOLOGY; OFFICE WORKER; OUTCOME ASSESSMENT; PEROPERATIVE COMPLICATION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; RECURRENT DISEASE; RENOVASCULAR HYPERTENSION; RESISTANT HYPERTENSION; SAFETY; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; URINARY TRACT INFECTION; ADRENERGIC SYSTEM; ARTERIAL PRESSURE; BLOOD PRESSURE MEASUREMENT; CATHETER ABLATION; DRUG EFFECT; DRUG RESISTANCE; EQUIPMENT DESIGN; HYPERTENSION; INNERVATION; KIDNEY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; SYMPATHECTOMY; TIME; TREATMENT OUTCOME; DRUG EFFECTS;

ANTIHYPERTENSIVE AGENTS; ARTERIAL PRESSURE; BLOOD PRESSURE DETERMINATION; CATHETER ABLATION; DRUG RESISTANCE; EQUIPMENT DESIGN; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; KIDNEY; PREDICTIVE VALUE OF TESTS; RESEARCH DESIGN; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; TREATMENT OUTCOME;

EID: 84894349227     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV9SRA16     Document Type: Article

References (37)

1. Ukena C, Mahfoud F, Kindermann I, Barth C, Lenski M, Kindermann M, Brandt MC, Hoppe UC, Krum H, Esler M, Sobotka PA, Böhm M. Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension. J Am Coll Cardiol. 2011;58:1176-82.
2. Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903-9.
3. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275-81.
4. Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, Hoppe UC, Vonend O, Rump LC, Sobotka PA, Krum H, Esler M, Böhm M. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension. Circulation. 2011;123:1940-6.
5. Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, Hoppe UC, Vonend O, Rump LC, Sobotka PA, Krum H, Esler M, Böhm M. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol. 2012;59:901-9.
6. Brandt MC, Reda S, Mahfoud F, Lenski M, Böhm M, Hoppe UC. Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension. J Am Coll Cardiol. 2012;60:1956-65.
7. Mahfoud F, Cremers B, Janker J, Link B, Vonend O, Ukena C, Linz D, Schmieder R, Rump LC, Kindermann I, Sobotka PA, Krum H, Scheller B, Schlaich M, Laufs U, Böhm M. Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension. 2012;60:419-24.
8. Zuern CS, Rizas KD, Eick C, Stoleriu C, Bunk L, Barthel P, Balletshofer B, Gawaz M, Bauer A. Effects of renal sympathetic denervation on 24-hour blood pressure variability. Front Physiol. 2012;3:1-8.
9. Mabin T, Sapoval M, Cabane V, Stemmett J, Iyer M. First experience with endovascular ultrasound renal denervation for the treatment of resistant hypertension. EuroIntervention. 2012;8:57-61.
10. Prochnau D, Figulla HR, Surber R. Efficacy of renal denervation with a standard EP catheter in the 24-h ambulatory blood pressure monitoring-long-term follow-up. Int J Cardiol. 2012;157:447-8.
11. Himmel F, Weil J, Reppel M, Mortensen K, Franzen K, Ansgar L, Schunkert H, Bode F. Improved heart rate dynamics in patients undergoing percutaneous renal denervation. J Clin Hypertens. 2012;14:654-5.
12. Investigators Symplicity HTN-1. Krum H, Barman N, Schlaich M, Sobotka P, Esler M, Mahfoud F, Bohm M, Dunlap M, Sadowski J, Bartus K, Kapelak B, Rocha-Singh KJ, Katholi RE, Witkowski A, Kadziela J, Januszewicz A, Prejbisz A, Walton AS, Sievert H, Id D, Wunderlich N, Whitbourn R, Rump LC, Vonend O, Saleh A, Thambar S, Nanra R, Zeller T, Erglis A, Sagic D, Boskovic S, Brachmann J, Schmidt M, Wenzel UO, Bart BA, Schmieder RE, Scheinert D, Börgel J, Straley C. Catheter-based renal sympathetic denervation for resistant hypertension. Hypertension. 2011;57:911-7.
13. Simonetti G, Spinelli A, Gandini R, Da Ros V, Gaspari E, Coco I, De Francesco M, Santucci D, Di Daniele N, Lauro R. Endovascular radiofrequency renal denervation in treating refractory arterial hypertension: a preliminary experience. Radiol Med (Torino). 2012;117:426-44.
14. Voskuil M, Verloop WL, Blankestijn PJ, Agostoni P, Stella PR, Doevendans PA. Percutaneous renal denervation for the treatment of resistant essential hypertension: the first Dutch experience. Neth Heart J. 2011;19:319-23.
15. Witkowski A, Prejbisz A, Florczak E, Kadziela J, Sliwinski P, Bielen P, Michalowska I, Kabat M, Warchol E, Januszewicz M, Narkiewicz K, Somers VK, Sobotka PA, Januszewicz A. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension. 2011;58:559-65.
16. Prochnau D, Lucas N, Kuehnert H, Figulla HR, Surber R. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter. EuroIntervention. 2012;7:1077-80.
17. Vase H, Mathiassen ON, Kaltoft A, Pedersen EB, Christensen KL, Buus NH, Lederballe O, Lassen JF, Bøtker HE, Thuesen L. Catheterbased renal denervation for treatment of resistant hypertension. Dan Med J. 2012;59:1-6.
18. Hering D, Mahfoud F, Walton AS, Krum H, Lambert GW, Lambert EA, Sobotka PA, Böhm M, Cremers B, Esler MD, Schlaich MP. Renal denervation in moderate to severe CKD. J Am Soc Nephrol. 2012;23:1250-7.
19. Mylotte D, Benamer H, Unterseeh T, Louvard Y, Morice M-C, Garot P, Lefèvre T. Percutaneous renal denervation for resistant hypertension: real world outcomes. J Am Coll Cardiol. 2012;59:E1708.
20. Verloop W, Spiering W, Agostoni P, Stella P, Onsea K, Doevendans P, Voskuil P. 6-months follow up in a real life situation after renal denervation. J Am Coll Cardiol. 2012;59:E1706.
21. Esler MD, Krum H, Schlaich M, Schmieder RE, Böhm M, Sobotka PA; Symplicity HTN-2 Investigators. Renal sympathetic denervation for treatment of resistant hypertension: one-year results from the SYMPLICITY HTN-2 randomized, controlled trial. Circulation. 2012;126:2976-82.
22. Ukena C, Mahfoud F, Spies A, Kindermann I, Linz D, Cremers B, Laufs U, Neuberger HR, Böhm M. Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension. Int J Cardiol. 2012 Aug 20. [Epub ahead of print]
23. Mortensen K, Franzen K, Himmel F, Bode F, Schunkert H, Weil J, Reppel M. Catheter-based renal sympathetic denervation improves central hemodynamics and arterial stiffness: a pilot study. J Clin Hypertens. 2012;14:861-70.
24. Fontenla A, García-Donaire JA, Hernández F, Segura J, Salgado R, Cerezo C, Ruilope LM, Arribas F. Management of Resistant Hypertension in a Multidisciplinary Unit of Renal Denervation: Protocol and Results. Rev Esp Cardiol. 2012 Dec 11. [Epub ahead of print]
25. Schlaich MP, Bart B, Hering D , Walton A , Marusic P, Mahfoud F, Böhm M, Lambert EA, Krum H, Sobotka PA, Schmieder RE, Ika-Sari C, Eikelis N, Straznicky N, Lambert GW, Esler MD. Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease. Int J Cardiol. 2013 Feb 28. [Epub ahead of print]
26. Krum H, Barman N, Schlaich M, Sobotka P, Esler M, Mahfoud F. Long-term follow-up of catheter-based renal sympathetic denervation for resistant hypertension confirms durable blood pressure reduction. J Am Coll Cardiol. 2012;59:E1705.
27. O'Brien E, Sheridan J, O'Malley K. Dippers and non-dippers. Lancet. 1988;2:397.
28. Hansen JM, Abildgaard U, Fogh-Andersen N, Kanstrup IL, Bratholm P, Plum I, Strandgaard S. The transplanted human kidney does not achieve functional reinnervation. Clin Sci (Lond). 1994;87:13-20.
29. Kaye DM, Esler M, Kingwell B, McPherson G, Esmore D, Jennings G. Functional and neurochemical evidence for partial cardiac sympathetic reinnervation after cardiac transplantation in humans. Circulation. 1993; 88:1110-8.
30. Schmieder RE, Redon J, Grassi G, Kjeldsen SE, Mancia G, Narkiewicz K, Parati G, Ruilope L, van de Borne P, Tsioufis C. ESH position paper: renal denervation-An interventional therapy of resistant hypertension. J Hypertens. 2012; 30:837-41.
31. Caulfield M, de Belder M, Cleveland T, Collier D, Deanfield J, Gray H, Knight C, Lobo M, Matson M, Moss J, Poulter N, Simpson I, Tomson C, Williams B. The Joint UK Societies' consensus statement on renal denervation for resistant hypertension. http://www.bcs.com/pages/news-full.asp?NewsID=19792021
32. Volpe M, Agabiti-Rosei E, Ambrosioni E, Cottone S, Cuspidi C, Borghi C, De Luca N, Fallo F, Ferri C, Mancia G, Morganti A, Muiesan ML, Sarzani R, Sechi L, Tocci G, Virdis A; Società Italiana dell'Ipertensione Arteriosa. Renal denervation for the treatment of resistant hypertension: definition, patient selection and description of the procedure. 2012 Position paper of the Italian Society of Hypertension. G Ital Cardiol. 2012;13:846-52.
33. Pathak A, Girerd X, Azizi M, Benamer H, Halimi JM, Lantelme P, Lefevre T, Sapoval M. Expert consensus: renal denervation for the treatment of hypertension. Diagn Interv Imaging. 2012;93:386-94.
34. Weber T, Zweiker R, Watschinger B, Grüner P, Koppelstätter C, Brandt M.C, Horina J, Brussee H, Hohenstein K, Lambert T, Auer J, Hoppe U.C. Clinical application of interventional renal sympathetic denervation: recommendations of the Austrian Society of Hypertension. Wien Klin Wochenschr. 2012;124:789-98.
35. Mahfoud F, Vonend O, Bruck H, Clasen W, Eckert S, Frye B, Haller H, Hausberg M, Hoppe UC, Hoyer J, Hahn K, Keller T, Kramer BK, Kreutz R, Potthoff SA, Reinecke H, Schmieder R, Schwenger V, Kintscher U, Böhm M, Rump LC. Interventionelle renale Sympathikusdenervation zur Behandlung der therapieresistenten Hypertonie [Expert consensus statement on interventional renal sympathetic denervation for hypertension treatment]. Dtsch Med Wochenschr. 2011;136:2418-24.
36. Vonend O, Antoch G, Rump LC, Blondin D. Secondary rise in blood pressure after renal denervation. Lancet. 2012;380:778.
37. Kaltenbach B, Id D, Franke JC, Sievert H, Hennersdorf M, Maier J, Bertog SC. Renal artery stenosis after renal sympathetic denervation. J Am Coll Cardiol. 2012;60:2694-5.